Cargando…

Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity

BACKGROUND/PURPOSE: The LFA REAL™ is a measurement system for evaluating lupus disease activity from both clinician and patient perspectives. Patients’ viewpoints are captured using a patient-reported outcome (PRO) questionnaire. A series of visual analog scales are designed to rate disease severity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Askanase, Anca D., Daly, R. Paola, Okado, Miya, Neville, Kayla, Pong, Avery, Hanrahan, Leslie M., Merrill, Joan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555910/ https://www.ncbi.nlm.nih.gov/pubmed/31174541 http://dx.doi.org/10.1186/s12955-019-1151-8

Ejemplares similares

Preliminary test of the LFA rapid evaluation of activity in lupus (LFA-REAL): an efficient outcome measure correlates with validated instruments
por: Askanase, Anca, et al.
Publicado: (2015)

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
por: Thanou, Aikaterini, et al.
Publicado: (2019)

Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials
por: Kim, Mimi, et al.
Publicado: (2018)

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2020)

Lupus clinical trials and the promise of future therapies
por: Khalili, Leila, et al.
Publicado: (2023)

Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America
por: Wallace, Daniel J, et al.
Publicado: (2019)

TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
por: Suh, Chang-Hee, et al.
Publicado: (2010)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)

A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2022)

Lupus community panel proposals for optimising clinical trials: 2018
por: Merrill, Joan T, et al.
Publicado: (2018)

Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
por: Izmirly, Peter, et al.
Publicado: (2019)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.
por: Li, Xiao, et al.
Publicado: (2016)

Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus
por: Kapoor, Teja, et al.
Publicado: (2020)

Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey
por: Birt, Julie A., et al.
Publicado: (2021)

Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies
por: Bagavant, Harini, et al.
Publicado: (2021)

Bilateral Lupus Chorioretinopathy in a Patient With Active Systemic Lupus Erythematosus
por: David, Sharoon, et al.
Publicado: (2022)

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE
por: Askanase, Anca D, et al.
Publicado: (2023)

COVID-19 and systemic lupus erythematosus: a case series
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2020)

A lupus explanation
por: Leslie, Mitch
Publicado: (2001)

Cell-bound complement activation products associate with lupus severity in SLE
por: Arriens, Cristina, et al.
Publicado: (2020)

ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis
por: Geraldino-Pardilla, Laura, et al.
Publicado: (2016)

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
por: Xue, Jing, et al.
Publicado: (2017)

Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography
por: Perel-Winkler, Alexandra, et al.
Publicado: (2018)

Two complications in patients with systemic lupus erythematosus: lupus cystitis and lupus enteritis
por: Wang, Gang, et al.
Publicado: (2022)

Impact of heart rate variability, a marker for cardiac health, on lupus disease activity
por: Thanou, Aikaterini, et al.
Publicado: (2016)

On Lupus
por: Milton, T. L.
Publicado: (1892)

Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus
por: Aljaberi, Najla, et al.
Publicado: (2022)

Occult systemic lupus erythematosus with active lupus nephritis presenting as Libman-Sacks endocarditis
por: Kasar, Pankajkumar Ashok, et al.
Publicado: (2012)

Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials
por: Corapi, Kristin M, et al.
Publicado: (2015)

Lupus enteritis as the only active manifestation of systemic lupus erythematosus: A case report
por: Gonzalez, Adalberto, et al.
Publicado: (2019)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Role of lupus retinopathy in systemic lupus erythematosus
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2016)

Relapsing lupus enteritis in systemic lupus erythematosus
por: Kim, Yaerim, et al.
Publicado: (2016)

Lupus Enteritis: An Uncommon Presentation of Lupus Flare
por: Potera, Joanna, et al.
Publicado: (2021)

Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry
por: Kim, Seong-Kyu, et al.
Publicado: (2018)

Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Askanase, Anca D., et al.
Publicado: (2020)

Treatment Satisfaction in Systemic Lupus Erythematosus: Development of a Patient-Reported Outcome Measure
por: Mathias, Susan D., et al.
Publicado: (2017)

Immune understudies combat lupus
por: Leslie, Mitch
Publicado: (2009)

Biological impact of iberdomide in patients with active systemic lupus erythematosus
por: Lipsky, Peter E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_28famtgep8kkmh1jivt9n1tio2